Page last updated: 2024-11-01

niclosamide and Nerve Degeneration

niclosamide has been researched along with Nerve Degeneration in 1 studies

Niclosamide: An antihelmintic that is active against most tapeworms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p48)
niclosamide : A secondary carboxamide resulting from the formal condensation of the carboxy group of 5-chlorosalicylic acid with the amino group of 2-chloro-4-nitroaniline. It is an oral anthelmintic drug approved for use against tapeworm infections.

Nerve Degeneration: Loss of functional activity and trophic degeneration of nerve axons and their terminal arborizations following the destruction of their cells of origin or interruption of their continuity with these cells. The pathology is characteristic of neurodegenerative diseases. Often the process of nerve degeneration is studied in research on neuroanatomical localization and correlation of the neurophysiology of neural pathways.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Goulding, SR1
Lévesque, M1
Sullivan, AM1
Collins, LM1
O'Keeffe, GW1

Other Studies

1 other study available for niclosamide and Nerve Degeneration

ArticleYear
Quinacrine and Niclosamide Promote Neurite Growth in Midbrain Dopaminergic Neurons Through the Canonical BMP-Smad Pathway and Protect Against Neurotoxin and α-Synuclein-Induced Neurodegeneration.
    Molecular neurobiology, 2021, Volume: 58, Issue:7

    Topics: alpha-Synuclein; Animals; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Cell Line, Tumo

2021